Follow The Filings

UTHR United Therapeutics

United Therapeutics earnings company data as of 4:45 AM ET 11/1

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 4 Nov EPS 6.47 — —
Rev $781.1M — —

Insider trades

Open-market buys and sales by UTHR's executives, directors and 10% owners in the last 12 months, from their Form 4s

All UTHR insider trades
  • $864K bought by 1 insider
  • $8.8M sold by 5 insiders outside a trading plan
  • $1.4B sold by 8 insiders under 10b5-1 plans
  1. Martine A Rothblatt CEO
    Planned sale
    $5.7M 9,500 shares at $594.78 2.8% of stake
    Traded Oct 29 Filed Oct 30
    ↗
  2. Martine A Rothblatt CEO
    Planned sale
    $5.6M 9,500 shares at $585.49 2.8% of stake
    Traded Oct 28 Filed Oct 29
    ↗
  3. Martine A Rothblatt CEO
    Planned sale
    $5.6M 9,500 shares at $587.73 2.8% of stake
    Traded Oct 27 Filed Oct 28
    ↗
  4. Martine A Rothblatt CEO
    Planned sale
    $5.6M 9,500 shares at $588.64 2.8% of stake
    Traded Oct 26 Filed Oct 27
    ↗
  5. Martine A Rothblatt CEO
    Planned sale
    $5.5M 9,500 shares at $582.76 2.8% of stake
    Traded Oct 23 Filed Oct 26
    ↗
  6. Martine A Rothblatt CEO
    Planned sale
    $5.5M 9,500 shares at $583.38 2.8% of stake
    Traded Oct 22 Filed Oct 23
    ↗
  7. Martine A Rothblatt CEO
    Planned sale
    $5.3M 9,500 shares at $560.07 2.8% of stake
    Traded Oct 21 Filed Oct 22
    ↗
  8. Martine A Rothblatt CEO
    Planned sale
    $5.3M 9,500 shares at $553.87 2.8% of stake
    Traded Oct 20 Filed Oct 21
    ↗
  9. Martine A Rothblatt CEO
    Planned sale
    $5.2M 9,500 shares at $543.32 2.8% of stake
    Traded Oct 19 Filed Oct 20
    ↗
  10. Martine A Rothblatt CEO
    Planned sale
    $5.1M 9,500 shares at $534.66 2.8% of stake
    Traded Oct 16 Filed Oct 19
    ↗
  11. Paul A Mahon EVP & General Counsel
    Planned sale
    $4.5M 8,300 shares at $544.30 16% of stake
    Traded Oct 15 Filed Oct 16
    ↗
  12. Martine A Rothblatt CEO
    Planned sale
    $5.2M 9,500 shares at $546.65 2.8% of stake
    Traded Oct 15 Filed Oct 16
    ↗
  13. Martine A Rothblatt CEO
    Planned sale
    $5.1M 9,500 shares at $539.99 2.8% of stake
    Traded Oct 14 Filed Oct 15
    ↗
  14. Martine A Rothblatt CEO
    Planned sale
    $5.2M 9,500 shares at $545.52 2.8% of stake
    Traded Oct 13 Filed Oct 14
    ↗
  15. Martine A Rothblatt CEO
    Planned sale
    $5.2M 9,500 shares at $550.70 2.8% of stake
    Traded Oct 12 Filed Oct 13
    ↗

Also filed in the last 12 months, not counted as buying or selling: 335 option exercises, 8 share withholdings for taxes, and 4 gifts.

SEC filings

Recent issuer filings from EDGAR, 2 shown.

Filed Form Detail Links
8-K 8.01,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 2 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.